Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
About
Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. Their pioneering approach leverages a unique ability to decode the interaction between the gut microbiome and the immune system, using a proprietary Mimicry platform to identify novel therapeutics from a vast database of gut microbiome proteins. The company is advancing pipelines of drug candidates, including OncoMimics™ for cancer and EndoMimics™ for immune diseases.
Tags
Total Employees
33
Current headcount
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Enterome do?
Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. Their pioneering approach leverages a unique ability to decode the interaction between the gut microbiome and the immune system, using a proprietary Mimicry platform to identify novel therapeutics from a vast database of gut microbiome proteins. The company is advancing pipelines of drug candidates, including OncoMimics™ for cancer and…
How much funding has Enterome raised?
Enterome has raised a total of $124M in funding. The most recent round on record is Later Stage VC.
Where is Enterome headquartered?
Enterome is headquartered in Paris, France.
When was Enterome founded?
Enterome was founded in 2012.
What industry does Enterome operate in?
Enterome operates in Biotechnology, Drug Discovery, Oncology, Immunotherapy, Microbiome, Clinical Trials.
How many employees does Enterome have?
Enterome has approximately 33 people on record.